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Abstract
Background: Several high throughput technologies have been employed to identify differentially regulated genes
that may be molecular targets for drug discovery. Here we compared the sets of differentially regulated genes
discovered using two experimental approaches: a subtracted suppressive hybridization (SSH) cDNA library
methodology and Affymetrix GeneChip® technology. In this "case study" we explored the transcriptional pattern
changes during the in vitro differentiation of human monocytes to myeloid dendritic cells (DC), and evaluated the
potential for novel gene discovery using the SSH methodology.
Results: The same RNA samples isolated from peripheral blood monocyte precursors and immature DC (iDC)
were used for GeneChip microarray probing and SSH cDNA library construction. 10,000 clones from each of the
two-way SSH libraries (iDC-monocytes and monocytes-iDC) were picked for sequencing. About 2000 transcripts
were identified for each library from 8000 successful sequences. Only 70% to 75% of these transcripts were
represented on the U95 series GeneChip microarrays, implying that 25% to 30% of these transcripts might not
have been identified in a study based only on GeneChip microarrays. In addition, about 10% of these transcripts
appeared to be "novel", although these have not yet been closely examined. Among the transcripts that are also
represented on the chips, about a third were concordantly discovered as differentially regulated between iDC
and monocytes by GeneChip microarray transcript profiling. The remaining two thirds were either not inferred
as differentially regulated from GeneChip microarray data, or were called differentially regulated but in the
opposite direction. This underscores the importance both of generating reciprocal pairs of SSH libraries, and of
real-time RT-PCR confirmation of the results.
Conclusions: This study suggests that SSH could be used as an alternative and complementary transcript
profiling tool to GeneChip microarrays, especially in identifying novel genes and transcripts of low abundance.
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Background
Gene expression profiling has become an invaluable tool
in functional genomics. Since the mid-1990's, DNA
microarrays [1-3], cDNA subtraction [4-7] and Serial
Analysis of Gene Expression (SAGE) [8] have emerged as
the leading transcript profiling technologies in the global
analysis of biological systems. One of the high through-
put technologies, high-density oligonucleotide Gene-
Chip® microarrays, manufactured by Affymetrix [1,3,9],
makes it possible to simultaneously measure the relative
abundance of thousands of mRNAs in a cell. However,
DNA microarray technology is limited by its insensitivity
to transcripts of low abundance [10]. A similar low sensi-
tivity was also seen with SAGE [10]. However, recently a
PCR-select cDNA subtraction method (called suppressive,
subtractive hybridization, or SSH) was developed by
Clontech, which, due to a normalization step to equalize
the abundance of cDNAs within the target population,
makes it possible to detect some low abundance tran-
scripts [4,7]. Although custom DNA microarrays have
been used in combination with the cDNA subtraction
technology in identifying differentially expressed genes
[11-15], no direct comparison of the sensitivity and bias
of the SSH and GeneChip technologies has been done so
far.
In order to comparatively evaluate the SSH and GeneChip
technologies, we explored the similarities and differences
in regulated genes discovered using SSH and GeneChip
microarrays. We compared the regulated genes identified
through SSH with the genes found to be differentially reg-
ulated using the GeneChip microarrays in a human den-
dritic cell (DC) differentiation paradigm. We regard this
as a "case study" of the potential for novel gene discovery
using SSH methodology, that would not be accessible
using Affymetrix profiling alone. The same RNA samples
isolated from immature DC (iDC) and RNA samples iso-
lated from monocytes were used for GeneChip microarray
probing and SSH library construction. Overall, about two
thirds of the transcripts identified using SSH methodology
were not identified using GeneChip microarrays alone.
These results suggest that SSH could be used as an alterna-
tive and complimentary transcript profiling tool to
Affymetrix GeneChip microarrays, especially in identify-
ing novel genes or transcripts of low abundance.
Results
Genes not represented on Affymetrix GeneChip 
microarrays can be identified through SSH
Reciprocally subtracted cDNA libraries between immature
dendritic cells (iDC) and monocytes were generated using
the SSH technology developed by Clontech (H56 stands
for iDC minus monocytes, and H57 stands for monocytes
minus iDC). Deep sequencing of the SSH cDNA libraries
were carried out by randomly picking 10000 clones from
each library for DNA sequence analysis. After accumulat-
ing more than 8000 lanes of successful sequences for each
library, a total of 1940 transcripts were identified for H56.
These transcripts were further extended in silico as
described in Methods (Figure 1), and the extended tran-
scripts were mapped to Affymetrix GeneChip microarray
qualifiers. About 73% of the transcripts identified in H56
were represented on the U95 series GeneChip microarrays
(Figure 2). However, about 17% of the transcripts identi-
fied through deep sequencing of the cDNA subtractive
library were not represented on those chips hence could
not have been identified in a study based purely on Gene-
Chip microarray analysis. This number did not change
significantly when the newer U133 series GeneChip
microarrays were used (data not shown). In addition,
about 10% of the transcripts identified appeared to be
novel sequences without any match in the three cDNA
databases we searched, and it is unlikely that these tran-
scripts were represented on GeneChip microarrays.
Certain genes present in the SSH libraries and represented 
on GeneChip microarrays were not detected through 
GeneChip microarray analysis
To find out how many of the SSH detected genes with
probes on the GeneChip microarrays can actually be
detected by the Affymetrix technology, we used the sub-
tracted cDNA to synthesize labeled complimentary RNA
(cRNA) targets for the GeneChip microarrays. A T7 pro-
moter in the SSH PCR primers allows us to perform in vitro
transcription with the SSH cDNA. Since the SSH library is
derived from cDNA primed from the 3' end, we assume
that any transcripts detected by sequencing the library are
potentially represented by 3' fragments, whether or not
the sequenced fragment is localized to the 3' end of the
transcript. This is critical because Affymetrix probes are
designed to interact with the 3' regions of the targeted
transcripts. When the GeneChip microarrays were
screened with targets made from the SSH cDNA, 571 out
of the 1409 transcripts were given "absent" calls, suggest-
ing that no positive signals can be detected on the
GeneChip microarrays for these transcripts, even though
the presence of these 571 transcripts had been confirmed
by sequencing (Figure 3a). Next we asked the question
whether the transcripts undetectable by the GeneChip
microarrays were limited only to transcripts of low abun-
dance. Although the abundance of genes had been nor-
malized in the SSH, the frequency of each gene in the SSH
cDNA library can still be used as a relative indicator for its
abundance because the same SSH cDNA samples were
used to label the cRNA targets for the GeneChip microar-
rays. Here we used the number of sequenced cDNA clones
belonging to each transcript as a measurement of the copy
number of this transcript in the SSH cDNA library. As
shown in Figure 3b, the transcripts scored as "absent"
using GeneChip microarrays include genes with high andBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
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low copy numbers. The distribution pattern of the copy
numbers of this group was very similar to the group of
transcripts scored as "present" by the GeneChip microar-
rays. This suggests that there are some inefficiencies in the
GeneChip microarray technology that are independent of
transcript abundance.
Discrepancy between genes identified through SSH and 
genes identified through GeneChip microarray analysis
Among the transcripts that were found in the H56 library
(iDC minus monocytes) and were also detectable on the
GeneChip microarrays, about a third were concordantly
discovered as up-regulated in iDC based on GeneChip
microarray profiling using non-subtracted RNA samples
(labeled as "GeneChip Concordant" in Figure 4a). The
remaining two thirds were either not inferred as differen-
tially regulated (labeled as "GeneChip no Change" in Fig-
ure 4a), or were called down-regulated in iDC according
to GeneChip microarray profiling data, contradictory to
their presence in the iDC minus monocytes SSH cDNA
library (labeled as "GeneChip Contradictory" in Figure
4a). As expected, the fraction appearing to contradict the
results of GeneChip microarray profiling is diminished
somewhat by subtracting out the 408 genes that appeared
in both of the two reciprocally subtracted libraries H56
and H57 (Figure 4b). This underscores the importance of
generating reciprocal pairs of SSH libraries.
Real time RT-PCR analysis of selective genes identified 
through SSH
To find out how genes with conflicting SSH data and
GeneChip microarray data are differentially expressed, we
used the more sensitive real time RT-PCR (TaqMan® anal-
ysis) to quantitate the RNA levels of selected genes in the
iDC and monocyte samples used for both the SSH and
GeneChip microarray analysis. As shown in Table 2,
Annotation and mapping of SSH sequences to GeneChip® microarray qualifiers (see Methods) Figure 1
Annotation and mapping of SSH sequences to GeneChip® microarray qualifiers (see Methods).
Sequencing subtracted library
Transcripts 
Sequences clustering/assembly
Celera Database  Incyte Database 
Yes
No No
Yes
Map to GeneChips® qualifiers 
Complete set of extended sequences with annotation, copy numbers 
Novel Sequences  Public Database 
YesBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
Page 4 of 10
(page number not for citation purposes)
among the 4 genes that appeared only in the H56 library
(iDC minus monocyte), but were suggested by GeneChip
microarray profiling to be upregulated in monocytes,
three of them have higher levels of expression in iDC,
while one of them has higher level of expression in mono-
cytes. These data suggests that there are false positives in
both SSH data and GeneChips® profiling data. By using
SSH in addition to GeneChip microarray profiling, we can
identify some differentially expressed genes with false
GeneChip microarray profiling results. However, more
sensitive RNA quantitative measures, such as real-time RT-
PCR analysis, are needed for more reliable verification of
these differentially expressed genes. Since all RNA quanti-
tation methods, including real-time RT-PCR, have their
limitations, further validation of the differential gene
expression pattern might need to be carried out. For exam-
ples, Northen blot may not be as sensitive as real-time RT-
PCR, but the size of the bands on the blot may be used as
indications for the specificity of the signals. If antibodies
are available for the gene products under study, Western
blot, flow cytometry and other protein analysis tools may
also be used to verify the differentially gene expression
pattern.
Discussion
In this study, we evaluated the similarities and differences
in genes discovered using SSH and GeneChip microarrays
by comparing the genes found to be differentially
expressed during DC differentiation from monocytes
using these two technical approaches. Our results showed
Genes not represented on Affymetrix GeneChip microarrays identified through SSH: Out of the 1940 transcripts in H56 SSH  library, 1409 are represented on the U95 series GeneChip microarrays Figure 2
Genes not represented on Affymetrix GeneChip microarrays identified through SSH: Out of the 1940 transcripts in H56 SSH 
library, 1409 are represented on the U95 series GeneChip microarrays. 333 of the transcripts have matches in the DNA 
sequence databases searched, but are not represented on the U95 series GeneChip microarray. 198 of the transcripts have no 
match in any of the DNA sequence databases searched.
Novel 
Transcripts
10%
Known 
Transcripts not 
on GeneChip 
microarrays
17%
Known 
Transcripts on 
GeneChip 
microarrays
73%BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
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Comparing the SSH data with GeneChip microarray data using subtracted samples as targets Figure 3
Comparing the SSH data with GeneChip microarray data using subtracted samples as targets. The GeneChip microarrays were 
screened with cRNA targets made from the same subtracted cDNA used for SSH. (a) Number of transcripts in the H56 SSH 
library identified as "present" or "absent" on the GeneChip microarrays. (b) The copy number of each transcript in the SSH 
library plotted against its detectability on the GeneChip microarrays. Each dot represents a distinct transcript identified in the 
H56 SSH cDNA library. The transcripts that can be detected by the GeneChip microarrays were given "present" calls, while 
the transcripts that cannot be detected by the GeneChip microarrays were given "absent" calls.
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Comparing the SSH data with GeneChip® data using non-subtracted RNA as targets Figure 4
Comparing the SSH data with GeneChip® data using non-subtracted RNA as targets. The GeneChip microarrays were 
screened with cRNA targets made from un-modified iDC and monocyte RNA samples, and the concordance of the SSH data 
with GeneChip data was shown when (a) all the transcripts in the H56 library were considered, or (b) when only the tran-
scripts unique to H56 were considered, after the transcripts appeared in both H56 and the reciprocally subtracted H57 librar-
ies were excluded.
GeneChip 
Contradictory 
17%
GeneChip 
Concordant 
34%
GeneChip 
No Change 
49%
172 transcripts: 342 transcripts:
487 transcripts:
GeneChip 
Contradictory 
23%
GeneChip
No Change
43%
GeneChip 
Concordant 
34%
320 transcripts: 481 transcripts:
608 transcripts:
(a)
(b)BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
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that among the genes identified in the SSH libraries, more
than half of those genes would not have been identified as
differentially expressed by using GeneChip microarrays
alone. Some of these genes were either novel or not repre-
sented on the GeneChip microarrays. However, a signifi-
cant number of genes were missed by GeneChip
microarray analysis despite the presence of probe sets for
these genes on the microarrays; whether this number
could be lower if the new and improved U133 series
GeneChip microarrays were used remains untested.
DNA microarrays are powerful tools that enable the glo-
bal analysis of a variety of complex biological systems.
The expression levels of thousands of genes can be moni-
tored simultaneously by using this high throughput, cost
effective technology. However, this technology is also
limited by its insensitivity to identify transcripts of low
abundance, i.e. genes expressed at low levels or in a small
fraction of the cells studied. Even some transcripts of high
abundance could be missed by DNA microarrays as well
due to the poor hybridization between the probes and the
labeled cRNA targets. One factor that could affect the
hybridization step is the sequence targeted by the Gene-
Chip probes. Since the GeneChip probes are 3'-biased to
match the target generation characteristics of the sample
amplification method, the sensitivity of some probes
could be compromised either due to their positioning
toward the 5' region, or the poor in vitro transcription effi-
ciency caused by the complexity of their sequences. The
complexity of these targeted sequences may also affect the
hybridization efficiency between the labeled cRNA targets
and the GeneChip probes. On the other hand, the nor-
malization step in the SSH protocol equalizes the abun-
dance of cDNAs within the target population and the
subtraction step excludes the common sequences between
the target and driver populations. So a comprehensive
analysis of at least 5000 to 10000 clones isolated from the
SSH cDNA libraries may enable the detection of some
transcripts of low abundance that would not be revealed
by other transcript profiling protocols. Genes not repre-
sented on the DNA microarrays, including some genes
with novel identities may also be identified through
sequencing the SSH cDNA libraries. However, the con-
struction and sequencing of subtractive cDNA libraries is
time consuming and labor intensive. These restrictions
will limit the number of samples that can be surveyed by
this technology in each study.
Conclusions
In practice, we suggest DNA microarrays as the preferred
approach for transcript profiling of a large number of
samples. This is especially true when the RNA is derived
from homogenous cell populations. [10]. However, in a
number of cases, such as clinical tissues, the relevant cell
type may be difficult to purify or in low abundance. In
these cases, normalized subtractive cDNA libraries are
preferable. Our results indicate that even though DNA
microarrays and SSH may each be preferred in distinct sit-
uations, neither technique can adequately identify all reg-
ulated genes. Thus, even when homogenous cell
populations were examined as we did in this study, more
than half of the genes discovered through sequencing the
SSH libraries would not have been identified by using
GeneChip® technology alone. In conclusion, using nor-
malized cDNA subtraction as an alternative and comple-
mentary transcript profiling tool to DNA microarrays will
Table 1: Probes and primers used in TaqMan® analysis
Accession Number Gene 1) Probe
2) Forward primer
3) Reversed primer
AB017568 USF1 1) TCAACAACTGGATCGTGCAGCTCTCC
2) TCGCCGCCGAGACAAG
3) TCCATAGAGCAGTCTGGGATTATCT
AL050134 CDNA DKFZp586K011 1) ACCTGATTGCCAAAGACCGTTTC
2) CATGTGCTTCGGATCCATGTAT
3) GGGTCTGACTTGCCCTTCAC
AF177765 Toll-like receptor 4 (TLR4) 1) ATGATGCCTTTGTTATCTACTCAAGC
2) GCATAAAGTA TGGTAGAGGTGAAAACAT
3) TCATTCCTTACCCAGTCCTCATC
V00572 phosphoglycerate kinase 1) ATCTGCTTAGCCCGAGTGACAGCCTCA
2) GTGGTCCTGAAAGCAGCAAGA
3) CCCCACAGGACCATTCCA
NM_002046 GAPDH 1) CAAGCTTCCCGTTCTCAGCC
2) GAAGGTGAAGGTCGGAGTC
3) GAAGATGGTGATGGGATT TCBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
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help identify novel genes and low abundance transcripts,
therefore achieving a more comprehensive global view of
the transcriptome in the biological system studied.
Methods
iDC generation and RNA preparation
CD14+  monocytes were isolated from the peripheral
blood samples of healthy donors by negative selection
using magnetic cell-sorting (Miltenyi, Auburn, CA) and
differentiated into immature dendritic cells (iDC) in
RPMI/10%FBS containing 1000 U/ml GM-CSF and 1000
U/ml IL-4 (Peprotech, Rocky Hill, NJ) [16-18]. Total RNA
of monocytes and iDC was isolated using RNAeasy mini-
kit (Qiagen, Valencia, CA).
Affymetrix GeneChip® Microarray studies
The cRNA labeling and hybridizations were performed
according to protocols from Affymetrix Inc. (Santa Clara,
CA). Briefly, the mRNA in 5 µg of total cellular RNA was
converted to double-stranded cDNA using Superscript
(Gibco-Invitrogen) with a T7-(dT)24 primer containing T7
RNA polymerase promoter. The cDNA was in vitro tran-
scribed to biotinylated complementary RNA (cRNA) by
incorporating biotin-CTP and biotin-UTP using Enzo Bio-
Array High Yield RNA labeling kit (Enzo Diagnostics, New
York, NY). Biotinylated cRNA from each sample was frag-
mented to approximately 40–100 bases and 10 µg of the
fragmented cRNA were hybridized to the Affymetrix
human U95 probe array series (A, B, C, D, and E) for 16 h
at 45°C with constant rotation at 60 rpm. Following
washes, the hybridized chips were sequentially stained
with streptavidin-phytoerythrin (Molecular Probes,
Eugene, OR), biotinylated goat anti-streptavidin (Vector
Laboratories, Burlingame, CA) and another streptavidin-
phytoerythrin for signal amplification. After a series of
washes, chips were scanned with an argon-ion laser con-
focal microscope (Hewlett-Packard, Palo Alto, CA) for flu-
orescence signal detection. All washes and staining
procedures were performed on an Affymetrix Fluidics sta-
tion. The raw expression data derived from Affymetrix
Microarray Suite 4.0.1 software gave each transcript an
absolute expression level (signal intensity) and a
"present" or "absent" call based on the signal/noise ratio.
The data were analyzed on two levels. At the detection
level, a call of "present" suggests that positive signal is
detected for a probe, while a call of "absence" suggests
that negative signal is detected for a probe. Gene expres-
sion ratio of different samples for each donor was inferred
using the PFOLD algorithm [19] that employs a Bayesian
estimation scheme for estimating the fold-change of gene
expression and also the significance of the change (P-
value). The comparison level analysis of the iDC and
monocytes defines a gene as up-regulated if the signal log
ratio between the iDC and monocyte samples is larger
than 1 (equals a 2-fold increase) and the target sample is
present. RNA samples from 3 individuals were analyzed.
The construction and sequencing of subtraction 
suppression hybridization (SSH) cDNA libraries
SSH libraries were generated using the reagents and proto-
cols provided by Clontech (Clontech, Palo Alto, CA). In
one SSH library (H56), the RNA from iDC was used as
"tester" and the RNA from monocytes was used as
"driver". In another SSH library (H57), the RNA from iDC
was used as "driver" and the RNA from monocytes was
used as "tester". In both cases, the starting RNA material
was a pool of the RNA samples from 3 individuals used in
the microarray experiment. RT-PCR analysis of the SSH
products showed that the level of the house-keeping gene
GAPDH decreased more than 1000 fold in both H56 and
H57 cDNA when compared with unsubtracted cDNA
(data not shown), suggesting that the subtraction proce-
dure was very effective. 10000 clones from each SSH
library were sequenced with M13 primers using the ABI
BigDye Terminator v2.0 Cycle Sequencing Kit (Applied
Biosystems, Foster City, California) and ABI 3700 DNA
Analyzers (Applied Biosystems), according to the manu-
facturers' protocols and manuals. The SSH cDNA was also
used to prepare the cRNA for GeneChip microarrays. In
vitro transcription was carried out from the T7 promoter
in the PCR primers for SSH. The cRNA generated was used
for GeneChip microarray hybridization as described
above.
Table 2: TaqMan® analysis of genes identified through SSH
Accession Number Gene description GeneChip (fold change)* Copies in H56/H57 TaqMan (fold change)*
AB017568 USF1 -3.41 1/0 -1.90
AL050134 cDNA DKFZp586K011 -2.98 1/0 +2.38
AF177765 Toll-like receptor 4 (TLR4) -2.24 2/0 +1.81
V00572 phosphoglycerate kinase -3.05 1/0 +1.34
* +, fold higher in iDC; -, fold higher in monocytes.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/26
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Annotation of the sequence results
Sequences generated through the deep sequencing were
clustered into contigs before being submitted to BLAST
searches of various online databases to elucidate the iden-
tity of clones. These included the National Center for Bio-
technology Information (NCBI) nr (nonredundant
GenBank, EMBL, DDBJ, and PDB), EST (nonredundant
GenBank, EMBL, and DDBJ EST divisions), Incyte
LifeSeq® database (Incyte, Palo Alto, CA) and Celera data-
base (Celera, Rockville, MD). The sequences extended in
silico were used to search for correspondent qualifiers on
the U95 series of GeneChip microarrays (Figure 1).
Real-time RT-PCR analysis
The probes and primers used in the TaqMan® (Applied
Biosystems, Foster City, CA) analysis are listed in Table 1.
Isolated RNA was treated with Dnase I at 37°C for 1 hour
to remove any genomic DNA contamination and first-
strand cDNA was then synthesized from the DNased RNA
using the ABI Reverse Transcriptase Kit (PE Applied Bio-
systems, Foster City, CA) in a reaction with RNA at 20 ng/
µl. cDNA samples were diluted in TE buffer at 1:20 and
plated in triplicate in adjacent wells at 10 µl in a 96-well
MicroAmp Optical plate (PE Applied Biosystems, Foster
City, CA). Three wells without any template were also
included on each plate as negative controls. Real time Taq-
Man PCR was performed using the ABI PRISM 7700
Sequence Detection System (PE Applied Biosystems, Fos-
ter City, CA). GAPDH was amplified along with the target
gene as an endogenous control in each well with VIC-
labeled probe to normalize expression between different
samples. The probes and primers for target gene and
GAPDH were diluted in the TaqMan Universal PCR Mas-
ter Mix (PE Applied Biosystems, Foster City, CA) and 15
µl of the reaction mix were added to each well. The probe
and primer concentrations in the final 25 µl reaction mix
were 250 nM and 900 nM for target gene, and 100 nM and
50 nM for GAPDH. Reactions were performed by an ini-
tial incubation at 50°C for 2 min and at 95°C for 10 min,
and then cycled at 95°C for 15 sec and 60°C for 1 min for
40 cycles. Output data generated by the instrument on-
board software Sequence Detector Version 1.6.3 (PE
Applied Biosystems, Foster City, CA) were transferred to a
custom designed Microsoft Excel macro for analysis. The
differential mRNA expression of each studied gene was
calculated with the comparative Ct method using the for-
mula 2∆∆Ct. Here, ∆Ct stands for the difference between
the target gene and the endogenous control, GAPDH,
adjusted by the Ct difference between these 2 genes in
negative controls, and ∆∆Ct equals to the difference
between the ∆Ct value of the target gene in iDC and
monocyte samples.
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